Lipoxin A4 Receptor Activation Is Distinct from That of the Formyl Peptide Receptor in Myeloid Cells: Inhibition of CD11/18 Expression by Lipoxin A4-Lipoxin A4 Receptor Interaction

This article is cited by 99 publications.

1. Olivier Corminboeuf and Xavier Leroy . FPR2/ALXR Agonists and the Resolution of Inflammation. Journal of Medicinal Chemistry 2015, 58 (2) , 537-559. https://doi.org/10.1021/jm501051x
2. Motonao Nakamura and Takao Shimizu . Leukotriene Receptors. Chemical Reviews 2011, 111 (10) , 6231-6298. https://doi.org/10.1021/cr100392s
3. Timothy P. O'Sullivan,, Karl S. A. Vallin,, Syed Tasadaque Ali Shah,, Jérôme Fakhry,, Paola Maderna,, Michael Scannell,, Andre L. F. Sampaio,, Mauro Perretti,, Catherine Godson, and, Patrick J. Guiry. Aromatic Lipoxin A4 and Lipoxin B4 Analogues Display Potent Biological Activities. Journal of Medicinal Chemistry 2007, 50 (24) , 5894-5902. https://doi.org/10.1021/jm060270d
4. Anna Waller,, Karyn L. Sutton,, Tamara L. Kinzer-Ursem,, Afaf Absood,, John R. Traynor,, Jennifer J. Linderman, and, Geneva M. Omann. Receptor Binding Kinetics and Cellular Responses of Six N-Formyl Peptide Agonists in Human Neutrophils. Biochemistry 2004, 43 (25) , 8204-8216. https://doi.org/10.1021/bi035335i
5. Sergio Sánchez-García, Rafael I. Jaén, María Fernández-Velasco, Carmen Delgado, Lisardo Boscá, Patricia Prieto. Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond. Pharmacological Research 2023, 197 , 106982. https://doi.org/10.1016/j.phrs.2023.106982
6. Qi Wang, Guang-xiao Xu, Qi-hang Tai, Yan Wang, . Lipoxin A4 Reduces Ventilator-Induced Lung Injury in Rats with Large-Volume Mechanical Ventilation. Mediators of Inflammation 2020, 2020 , 1-8. https://doi.org/10.1155/2020/6705985
7. George Hajishengallis, Triantafyllos Chavakis, John D. Lambris. Current understanding of periodontal disease pathogenesis and targets for host‐modulation therapy. Periodontology 2000 2020, 84 (1) , 14-34. https://doi.org/10.1111/prd.12331
8. Irundika H.K. Dias, Ivana Milic, Christian Heiss, Opeyemi S. Ademowo, Maria Cristina Polidori, Andrew Devitt, Helen R. Griffiths. Inflammation, Lipid (Per)oxidation, and Redox Regulation. Antioxidants & Redox Signaling 2020, 33 (3) , 166-190. https://doi.org/10.1089/ars.2020.8022
9. Yuanyuan Cheng, Jianhui Rong. Pro-resolving lipid mediators as therapeutic leads for cardiovascular diseases. Expert Opinion on Therapeutic Targets 2019, 23 (5) , 423-436. https://doi.org/10.1080/14728222.2019.1599360
10. Jesmond Dalli, Charles N Serhan. Identification and structure elucidation of the pro‐resolving mediators provides novel leads for resolution pharmacology. British Journal of Pharmacology 2019, 176 (8) , 1024-1037. https://doi.org/10.1111/bph.14336
11. Miguel Quiros, Asma Nusrat. Saving Problematic Mucosae: SPMs in Intestinal Mucosal Inflammation and Repair. Trends in Molecular Medicine 2019, 25 (2) , 124-135. https://doi.org/10.1016/j.molmed.2018.12.004
12. Nandini Krishnamoorthy, Raja-Elie E. Abdulnour, Katherine H. Walker, Braden D. Engstrom, Bruce D. Levy. Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases. Physiological Reviews 2018, 98 (3) , 1335-1370. https://doi.org/10.1152/physrev.00026.2017
13. Ruth X. Wang, Sean P. Colgan. Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses. Molecular Aspects of Medicine 2017, 58 , 93-101. https://doi.org/10.1016/j.mam.2017.02.002
14. Vasundhara Kain, Fei Liu, Veronika Kozlovskaya, Kevin. A. Ingle, Subhashini Bolisetty, Anupam Agarwal, Santosh Khedkar, Sumanth D. Prabhu, Eugenia Kharlampieva, Ganesh V. Halade. Resolution Agonist 15-epi-Lipoxin A4 Programs Early Activation of Resolving Phase in Post-Myocardial Infarction Healing. Scientific Reports 2017, 7 (1) https://doi.org/10.1038/s41598-017-10441-8
15. Bhagawat C. Subramanian, Ritankar Majumdar, Carole A. Parent. The role of the LTB 4 -BLT1 axis in chemotactic gradient sensing and directed leukocyte migration. Seminars in Immunology 2017, 33 , 16-29. https://doi.org/10.1016/j.smim.2017.07.002
16. Kimberly E. Hawkins, Kelly M. DeMars, Jon C. Alexander, Lauren G. de Leon, Sean C. Pacheco, Christina Graves, Changjun Yang, Austin O. McCrea, Jan C. Frankowski, Timothy J. Garrett, Marcelo Febo, Eduardo Candelario‐Jalil. Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A 4 analog: Protective mechanisms and long‐term effects on neurological recovery. Brain and Behavior 2017, 7 (5) https://doi.org/10.1002/brb3.688
17. Anju Singh, Tabassum Rahman, Rose Bartiss, Alireza Arabshahi, Jeevan Prasain, Stephen Barnes, Florin Marcel Musteata, Timothy J Sellati. Lipoxin A4, a 5-lipoxygenase pathway metabolite, modulates immune response during acute respiratory tularemia. Journal of Leukocyte Biology 2017, 101 (2) , 531-542. https://doi.org/10.1189/jlb.4A0815-365RR
18. Nagendra Sastry Yarla, Anupam Bishayee, Gautam Sethi, Pallu Reddanna, Arunasree M. Kalle, Bhadrapura Lakkappa Dhananjaya, Kaladhar S.V.G.K. Dowluru, Ramakrishna Chintala, Govinda Rao Duddukuri. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. Seminars in Cancer Biology 2016, 40-41 , 48-81. https://doi.org/10.1016/j.semcancer.2016.02.001
19. Hatice Hasturk, Alpdogan Kantarci. RETRACTED ARTICLE: Biological Mechanisms Relating Periodontitis and Diabetes. Current Oral Health Reports 2016, 3 (3) , 282-292. https://doi.org/10.1007/s40496-016-0100-4
20. George Hajishengallis, Niki M. Moutsopoulos, Evlambia Hajishengallis, Triantafyllos Chavakis. Immune and regulatory functions of neutrophils in inflammatory bone loss. Seminars in Immunology 2016, 28 (2) , 146-158. https://doi.org/10.1016/j.smim.2016.02.002
21. Antonio Recchiuti, Eleonora Cianci, Felice Simiele, Mario Romano. Lipoxins, Resolvins, and the Resolution of Inflammation. 2016, 211-239. https://doi.org/10.1007/978-3-319-27766-0_10
22. Mario Romano, Eleonora Cianci, Felice Simiele, Antonio Recchiuti. Lipoxins and aspirin-triggered lipoxins in resolution of inflammation. European Journal of Pharmacology 2015, 760 , 49-63. https://doi.org/10.1016/j.ejphar.2015.03.083
23. Murugesan V.S. Rajaram, Bin Ni, Claire E. Dodd, Larry S. Schlesinger. Macrophage immunoregulatory pathways in tuberculosis. Seminars in Immunology 2014, 26 (6) , 471-485. https://doi.org/10.1016/j.smim.2014.09.010
24. Giovanni Antico, Monica Aloman, Katja Lakota, Lucio Miele, Stefano Fiore, Snezna Sodin-Semrl. Uteroglobin, a Possible Ligand of the Lipoxin Receptor Inhibits Serum Amyloid A-Driven Inflammation. Mediators of Inflammation 2014, 2014 , 1-10. https://doi.org/10.1155/2014/876395
25. Stephen P.H. Alexander, Helen E. Benson, Elena Faccenda, Adam J. Pawson, Joanna L. Sharman, Michael Spedding, John A. Peters, Anthony J. Harmar, . The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors. British Journal of Pharmacology 2013, 170 (8) , 1459-1581. https://doi.org/10.1111/bph.12445
26. Julien Hanson, Nerea Ferreirós, Bernard Pirotte, Gerd Geisslinger, Stefan Offermanns. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A4. Biochemical Pharmacology 2013, 85 (12) , 1795-1802. https://doi.org/10.1016/j.bcp.2013.04.019
27. Ellen L Hughes, Patricia O Cover, Julia C Buckingham, Felicity NE Gavins. Role and interactions of annexin A 1 and oestrogens in the manifestation of sexual dimorphisms in cerebral and systemic inflammation. British Journal of Pharmacology 2013, 169 (3) , 539-553. https://doi.org/10.1111/j.1476-5381.2012.02146.x
28. Fabio Cattaneo, Melania Parisi, Rosario Ammendola. Distinct Signaling Cascades Elicited by Different Formyl Peptide Receptor 2 (FPR2) Agonists. International Journal of Molecular Sciences 2013, 14 (4) , 7193-7230. https://doi.org/10.3390/ijms14047193
29. George Hajishengallis, Triantafyllos Chavakis. Endogenous modulators of inflammatory cell recruitment. Trends in Immunology 2013, 34 (1) , 1-6. https://doi.org/10.1016/j.it.2012.08.003
30. Matthew Spite, Charles N. Serhan. Novel Lipid Mediators Promote Resolution of Acute Inflammation. Circulation Research 2010, 107 (10) , 1170-1184. https://doi.org/10.1161/CIRCRESAHA.110.223883
31. F.P.B. Nunes, B.C. Zychar, M.S. Della-Casa, S.C. Sampaio, L.R.C. Gonçalves, M.C. Cirillo. Crotoxin is responsible for the long-lasting anti-inflammatory effect of Crotalus durissus terrificus snake venom: involvement of formyl peptide receptors. Toxicon 2010, 55 (6) , 1100-1106. https://doi.org/10.1016/j.toxicon.2009.12.011
32. Gerard Bannenberg, Charles N. Serhan. A Novel Genus of Specialized Anti-Inflammatory and Pro-Resolution Lipid Mediators. 2010, 37-57. https://doi.org/10.1016/S1567-7443(10)70009-0
33. . 7TM RECEPTORS. British Journal of Pharmacology 2009https://doi.org/10.1111/j.1476-5381.2009.00501.x
34. . Leukotriene, lipoxin, oxoeicosanoid and resolvin E1. British Journal of Pharmacology 2009, S64-S65. https://doi.org/10.1111/j.1476-5381.2009.00501_37.x
35. M Spite, L Summers, TF Porter, S Srivastava, A Bhatnagar, CN Serhan. Resolvin D1 controls inflammation initiated by glutathione‐lipid conjugates formed during oxidative stress. British Journal of Pharmacology 2009, 158 (4) , 1062-1073. https://doi.org/10.1111/j.1476-5381.2009.00234.x
36. Driss El Kebir, Levente József, Wanling Pan, Lili Wang, Nicos A. Petasis, Charles N. Serhan, János G. Filep. 15-Epi-lipoxin A 4 Inhibits Myeloperoxidase Signaling and Enhances Resolution of Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine 2009, 180 (4) , 311-319. https://doi.org/10.1164/rccm.200810-1601OC
37. Jennie Karlsson, Anna-Lena Stenfeldt, Marie-Josèphe Rabiet, Johan Bylund, Huamei Fu Forsman, Claes Dahlgren. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels. Cell Calcium 2009, 45 (5) , 431-438. https://doi.org/10.1016/j.ceca.2009.02.002
38. Robert B. Zurier, Yee‐Ping Sun, Kerri L. George, Judith A. Stebulis, Ronald G. Rossetti, Ann Skulas, Erica Judge, Charles N. Serhan. Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti‐inflammatory eicosanoid, lipoxin A4. The FASEB Journal 2009, 23 (5) , 1503-1509. https://doi.org/10.1096/fj.08-118323
39. Bruce D. Levy, Jeffrey M. Drazen. Leukotrienes and Lipoxins. 2009, 283-292. https://doi.org/10.1016/B978-0-12-374001-4.00024-9
40. Clement E. Tagoe, Nada Marjanovic, Jean Y. Park, Edwin S. Chan, Aryeh M. Abeles, Mukundan Attur, Steven B. Abramson, Michael H. Pillinger. Annexin-1 Mediates TNF-α-Stimulated Matrix Metalloproteinase Secretion from Rheumatoid Arthritis Synovial Fibroblasts. The Journal of Immunology 2008, 181 (4) , 2813-2820. https://doi.org/10.4049/jimmunol.181.4.2813
41. Charles N. Serhan, Nan Chiang, Thomas E. Van Dyke. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nature Reviews Immunology 2008, 8 (5) , 349-361. https://doi.org/10.1038/nri2294
42. Eiji Ohara, Yoshitaka Kumon, Toshihiro Kobayashi, Hiroaki Takeuchi, Tetsuro Sugiura. Exocytosis of Neutrophil Formyl Peptide Receptor-Like 1 (fPRL1) Results in Downregulation of Cytoplasmic fPRL1 in Patients with Purulent Dermatitis. Clinical and Vaccine Immunology 2007, 14 (6) , 678-684. https://doi.org/10.1128/CVI.00426-06
43. Zhenhua Miao, Brett A. Premack, Zheng Wei, Yu Wang, Craig Gerard, Henry Showell, Maureen Howard, Thomas J. Schall, Robert Berahovich. Proinflammatory Proteases Liberate a Discrete High-Affinity Functional FPRL1 (CCR12) Ligand from CCL23. The Journal of Immunology 2007, 178 (11) , 7395-7404. https://doi.org/10.4049/jimmunol.178.11.7395
44. Hesham El‐Sharkawy, Alpdogan Kantarci, Jennifer Deady, Hatice Hasturk, Hongsheng Liu, Mohammad Alshahat, Thomas E. Van Dyke. Platelet‐Rich Plasma: Growth Factors and Pro‐ and Anti‐Inflammatory Properties. Journal of Periodontology 2007, 78 (4) , 661-669. https://doi.org/10.1902/jop.2007.060302
45. S. J. O'Meara, K. Rodgers, C. Godson. Lipoxins: update and impact of endogenous pro-resolution lipid mediators. 2007, 47-70. https://doi.org/10.1007/112_2006_0606
46. Atsushi Hashimoto, Yousuke Murakami, Hidero Kitasato, Izumi Hayashi, Hirahito Endo. Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation. Biomedicine & Pharmacotherapy 2007, 61 (1) , 81-85. https://doi.org/10.1016/j.biopha.2006.06.023
47. Nan Chiang, Charles N. Serhan, Sven-Erik Dahlén, Jeffrey M. Drazen, Douglas W. P. Hay, G. Enrico Rovati, Takao Shimizu, Takehiko Yokomizo, Charles Brink. The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo. Pharmacological Reviews 2006, 58 (3) , 463-487. https://doi.org/10.1124/pr.58.3.4
48. Hartmut Kühn, Valerie B. O’Donnell. Inflammation and immune regulation by 12/15-lipoxygenases. Progress in Lipid Research 2006, 45 (4) , 334-356. https://doi.org/10.1016/j.plipres.2006.02.003
49. Caroline Bonnans, Koichi Fukunaga, Marilyn A. Levy, Bruce D. Levy. Lipoxin A4 Regulates Bronchial Epithelial Cell Responses to Acid Injury. The American Journal of Pathology 2006, 168 (4) , 1064-1072. https://doi.org/10.2353/ajpath.2006.051056
50. S P H Alexander, A Mathie, J A Peters. Lipoxin. British Journal of Pharmacology 2006, 59 , S50-S50. https://doi.org/10.1038/sj.bjp.0706529
51. Richard P. G. Hayhoe, Ahmad M. Kamal, Egle Solito, Roderick J. Flower, Dianne Cooper, Mauro Perretti. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 2006, 107 (5) , 2123-2130. https://doi.org/10.1182/blood-2005-08-3099
52. Miriam Rodríguez-Sosa, Guillermo Elizondo, Rosa María López-Durán, Irma Rivera, Frank J. Gonzalez, Libia Vega. Over‐production of IFN‐γ and IL‐12 in AhR‐null mice. FEBS Letters 2005, 579 (28) , 6403-6410. https://doi.org/10.1016/j.febslet.2005.10.023
53. Edward Dennis, Richard Harkewicz, Rebecca Bowers-Gentry, Raymond Deems. Eicosanoid Lipidomics. 2005, 79-100. https://doi.org/10.1201/9781420027655.ch4
54. Charles N. Serhan. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005, 73 (3-4) , 141-162. https://doi.org/10.1016/j.plefa.2005.05.002
55. S. Fiore, G. Antico, M. Aloman, S. Sodin-Semrl. Lipoxin A4 biology in the human synovium. Role of the ALX signaling pathways in modulation of inflammatory arthritis. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005, 73 (3-4) , 189-196. https://doi.org/10.1016/j.plefa.2005.05.005
56. Nancy A. Louis, Kathryn E. Hamilton, Sean P. Colgan. Lipid mediator networks and leukocyte transmigration. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005, 73 (3-4) , 197-202. https://doi.org/10.1016/j.plefa.2005.05.006
57. János G. Filep, Tarek Khreiss, Levente József. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005, 73 (3-4) , 257-262. https://doi.org/10.1016/j.plefa.2005.05.014
58. Alpdogan Kantarci, Thomas E. Van Dyke. Lipoxin signaling in neutrophils and their role in periodontal disease. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005, 73 (3-4) , 289-299. https://doi.org/10.1016/j.plefa.2005.05.019
59. Stefano Fiorucci, Annarita Di Lorenzo, Barbara Renga, Silvana Farneti, Antonio Morelli, Giuseppe Cirino. Nitric Oxide (NO)-Releasing Naproxen (HCT-3012 [( S )-6-Methoxy-α-methyl-2-naphthaleneacetic Acid 4-(Nitrooxy)butyl Ester]) Interactions with Aspirin in Gastric Mucosa of Arthritic Rats Reveal a Role for Aspirin-Triggered Lipoxin, Prostaglandins, and NO in Gastric Protection. Journal of Pharmacology and Experimental Therapeutics 2004, 311 (3) , 1264-1271. https://doi.org/10.1124/jpet.104.072843
60. Qian Chen, David Wade, Kahori Kurosaka, Zhao Yuan Wang, Joost J. Oppenheim, De Yang. Temporin A and Related Frog Antimicrobial Peptides Use Formyl Peptide Receptor-Like 1 as a Receptor to Chemoattract Phagocytes. The Journal of Immunology 2004, 173 (4) , 2652-2659. https://doi.org/10.4049/jimmunol.173.4.2652
61. Huamei Fu, Johan Bylund, Anna Karlsson, Sara Pellmé, Claes Dahlgren. The mechanism for activation of the neutrophil NADPH‐oxidase by the peptides formyl‐Met‐Leu‐Phe and Trp‐Lys‐Tyr‐Met‐Val‐Met differs from that for interleukin‐8. Immunology 2004, 112 (2) , 201-210. https://doi.org/10.1111/j.1365-2567.2004.01884.x
62. S. Sodin-Semrl, A. Spagnolo, R. Mikus, B. Barbaro, J. Varga, S. Fiore. Opposing Regulation of Interleukin-8 and NF-kB Responses by Lipoxin A4 and Serum Amyloid a via the Common Lipoxin a Receptor. International Journal of Immunopathology and Pharmacology 2004, 17 (2) , 145-155. https://doi.org/10.1177/039463200401700206
63. Niamh E. Kieran, Paola Maderna, Catherine Godson. Lipoxins: Potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease. Kidney International 2004, 65 (4) , 1145-1154. https://doi.org/10.1111/j.1523-1755.2004.00487.x
64. Blaithin McMahon, Catherine Godson. Lipoxins: endogenous regulators of inflammation. American Journal of Physiology-Renal Physiology 2004, 286 (2) , F189-F201. https://doi.org/10.1152/ajprenal.00224.2003
65. Charles N. Serhan, Nan Chiang. Lipoxins and resolvins: Local mediators in endogenous anti-inflammation and resolution. 2004, 169-210. https://doi.org/10.1007/978-3-0348-7848-7_10
66. S. Sodin-Semrl, A. Spagnolo, B. Barbaro, J. Varga, S. Fiore. Lipoxin A 4 Counteracts Synergistic Activation of Human Fibroblast-like Synoviocytes. International Journal of Immunopathology and Pharmacology 2004, 17 (1) , 15-25. https://doi.org/10.1177/039463200401700103
67. Aram Elagoz, Duncan Henderson, Poda Suresh Babu, Sylvia Salter, Caroline Grahames, Lorna Bowers, Marie‐Odile Roy, Patricia Laplante, Eric Grazzini, Sultan Ahmad, Paola M C Lembo. A truncated form of CK β 8‐1 is a potent agonist for human formyl peptide‐receptor‐like 1 receptor. British Journal of Pharmacology 2004, 141 (1) , 37-46. https://doi.org/10.1038/sj.bjp.0705592
68. A. Betten, C. Dahlgren, S. Hermodsson, K. Hellstrand. Histamine Inhibits Neutrophil NADPH Oxidase Activity Triggered by the Lipoxin A4 Receptor-Specific Peptide Agonist Trp-Lys-Tyr-Met-Val-Met. Scandinavian Journal of Immunology 2003, 58 (3) , 321-326. https://doi.org/10.1046/j.1365-3083.2003.01301.x
69. Stefano Fiorucci, Eleonora Distrutti, Andrea Mencarelli, Antonio Morelli, Stefan A Laufor, Giuseppe Cirino, John L Wallace. Evidence that 5‐lipoxygenase and acetylated cyclooxygenase 2‐derived eicosanoids regulate leukocyte–endothelial adherence in response to aspirin. British Journal of Pharmacology 2003, 139 (7) , 1351-1359. https://doi.org/10.1038/sj.bjp.0705356
70. Rembert Koczulla, Georges von Degenfeld, Christian Kupatt, Florian Krötz, Stefan Zahler, Torsten Gloe, Katja Issbrücker, Pia Unterberger, Mohamed Zaiou, Corinna Lebherz, Alexander Karl, Philip Raake, Achim Pfosser, Peter Boekstegers, Ulrich Welsch, Pieter S. Hiemstra, Claus Vogelmeier, Richard L. Gallo, Matthias Clauss, Robert Bals. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. Journal of Clinical Investigation 2003, 111 (11) , 1665-1672. https://doi.org/10.1172/JCI17545
71. Felicity N. E. Gavins, Simon Yona, Ahmad M. Kamal, Roderick J. Flower, Mauro Perretti. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 2003, 101 (10) , 4140-4147. https://doi.org/10.1182/blood-2002-11-3411
72. Caroline Bonnans, Brigitte Mainprice, Pascal Chanez, Jean Bousquet, Valerie Urbach. Lipoxin A4 Stimulates a Cytosolic Ca2+Increase in Human Bronchial Epithelium. Journal of Biological Chemistry 2003, 278 (13) , 10879-10884. https://doi.org/10.1074/jbc.M210294200
73. Charles Brink, Sven-Erik Dahlén, Jeffrey Drazen, Jilly F. Evans, Douglas W. P. Hay, Simonetta Nicosia, Charles N. Serhan, Takao Shimizu, Takehiko Yokomizo. International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors. Pharmacological Reviews 2003, 55 (1) , 195-227. https://doi.org/10.1124/pr.55.1.8
74. Julio Aliberti, Charles Serhan, Alan Sher. Parasite-induced Lipoxin A4 Is an Endogenous Regulator of IL-12 Production and Immunopathology in Toxoplasma gondii Infection. The Journal of Experimental Medicine 2002, 196 (9) , 1253-1262. https://doi.org/10.1084/jem.20021183
75. De Yang, Qian Chen, Barry Gertz, Rong He, Michele Phulsuksombati, Richard D Ye, Joost J Oppenheim. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. Journal of Leukocyte Biology 2002, 72 (3) , 598-607. https://doi.org/10.1189/jlb.72.3.598
76. Paola Maderna, David C. Cottell, Giovanni Berlasconi, Nicos A. Petasis, Hugh R. Brady, Catherine Godson. Lipoxins Induce Actin Reorganization in Monocytes and Macrophages But Not in Neutrophils. The American Journal of Pathology 2002, 160 (6) , 2275-2283. https://doi.org/10.1016/S0002-9440(10)61175-3
77. Caroline Bonnans, Isabelle Vachier, Claude Chavis, Philippe Godard, Jean Bousquet, Pascal Chanez. Lipoxins Are Potential Endogenous Antiinflammatory Mediators in Asthma. American Journal of Respiratory and Critical Care Medicine 2002, 165 (11) , 1531-1535. https://doi.org/10.1164/rccm.200201-053OC
78. M. Resnati, I. Pallavicini, J. M. Wang, J. Oppenheim, C. N. Serhan, M. Romano, F. Blasi. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proceedings of the National Academy of Sciences 2002, 99 (3) , 1359-1364. https://doi.org/10.1073/pnas.022652999
79. I.M. Fierro, C.N. Serhan. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins. Brazilian Journal of Medical and Biological Research 2001, 34 (5) , 555-566. https://doi.org/10.1590/S0100-879X2001000500002
80. De Yang, Qian Chen, Yingying Le, Ji Ming Wang, Joost J. Oppenheim. Differential Regulation of Formyl Peptide Receptor-Like 1 Expression During the Differentiation of Monocytes to Dendritic Cells and Macrophages. The Journal of Immunology 2001, 166 (6) , 4092-4098. https://doi.org/10.4049/jimmunol.166.6.4092
81. Blaithin McMahon, Catherine Stenson, Fiona McPhillips, Aine Fanning, Hugh R. Brady, Catherine Godson. Lipoxin A4 Antagonizes the Mitogenic Effects of Leukotriene D4 in Human Renal Mesangial Cells. Journal of Biological Chemistry 2000, 275 (36) , 27566-27575. https://doi.org/10.1074/jbc.M001015200
82. Nan Chiang, Iolanda M. Fierro, Karsten Gronert, Charles N. Serhan. Activation of Lipoxin a4 Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation. The Journal of Experimental Medicine 2000, 191 (7) , 1197-1208. https://doi.org/10.1084/jem.191.7.1197
83. Claes Dahlgren, Thierry Christophe, Francois Boulay, Phoebus N. Madianos, Marie J. Rabiet, Anna Karlsson. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A4 receptor. Blood 2000, 95 (5) , 1810-1818. https://doi.org/10.1182/blood.V95.5.1810.005k06_1810_1818
84. Snezna Sodin-Semrl, Brunella Taddeo, Daniel Tseng, John Varga, Stefano Fiore. Lipoxin A4 Inhibits IL-1β-Induced IL-6, IL-8, and Matrix Metalloproteinase-3 Production in Human Synovial Fibroblasts and Enhances Synthesis of Tissue Inhibitors of Metalloproteinases. The Journal of Immunology 2000, 164 (5) , 2660-2666. https://doi.org/10.4049/jimmunol.164.5.2660
85. C. N. Serhan, B. D. Levy, C. B. Clish, K. Gronert, N. Chiang. Lipoxins, Aspirin-Triggered 15-epi-Lipoxin Stable Analogs and Their Receptors in Anti-Inflammation: A Window for Therapeutic Opportunity. 2000, 143-185. https://doi.org/10.1007/978-3-662-04047-8_8
86. János G. Filep, Christine Zouki, Nicos A. Petasis, Mohamed Hachicha, Charles N. Serhan. Anti-Inflammatory Actions of Lipoxin A4 Stable Analogs Are Demonstrable in Human Whole Blood: Modulation of Leukocyte Adhesion Molecules and Inhibition of Neutrophil-Endothelial Interactions. Blood 1999, 94 (12) , 4132-4142. https://doi.org/10.1182/blood.V94.12.4132
87. János G. Filep, Christine Zouki, Nicos A. Petasis, Mohamed Hachicha, Charles N. Serhan. Anti-Inflammatory Actions of Lipoxin A4 Stable Analogs Are Demonstrable in Human Whole Blood: Modulation of Leukocyte Adhesion Molecules and Inhibition of Neutrophil-Endothelial Interactions. Blood 1999, 94 (12) , 4132-4142. https://doi.org/10.1182/blood.V94.12.4132.424k25_4132_4142
88. Mohamed Hachicha, Marc Pouliot, Nicos A. Petasis, Charles N. Serhan. Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis. The Journal of Experimental Medicine 1999, 189 (12) , 1923-1930. https://doi.org/10.1084/jem.189.12.1923
89. Pauline Diamond, Ann McGinty, Declan Sugrue, Hugh R. Brady, Catherine Godson. Regulation of Leukocyte Trafficking by Lipoxins. cclm 1999, 37 (3) , 293-297. https://doi.org/10.1515/CCLM.1999.051
90. Charles N. Serhan, Tomoko Takano, Karsten Gronert, Nan Chiang, Clary B. Clish. Lipoxin and Aspirin-Triggered 15-epi-Lipoxin Cellular Interactions Anti-Inflammatory Lipid Mediators. cclm 1999, 37 (3) , 299-309. https://doi.org/10.1515/CCLM.1999.052
91. Shao Bo Su, Wanghua Gong, Ji-Liang Gao, Weiping Shen, Philip M. Murphy, Joost J. Oppenheim, Ji Ming Wang. A Seven-transmembrane, G Protein–coupled Receptor, FPRL1, Mediates the Chemotactic Activity of Serum Amyloid A for Human Phagocytic Cells. The Journal of Experimental Medicine 1999, 189 (2) , 395-402. https://doi.org/10.1084/jem.189.2.395
92. Charles N. Serhan, Tomoko Takano, Jane F. Maddox. Aspirin-Triggered 15-Epi-Lipoxin A4 and Stable Analogs of Lipoxin A4 are Potent Inhibitors of Acute Inflammation. 1999, 133-149. https://doi.org/10.1007/978-1-4615-4861-4_13
93. Jesper Z. Haeggström, Charles N. Serhan. Update on Arachidonic Acid Cascade. 1999, 51-92. https://doi.org/10.1007/978-1-59259-253-1_3
94. Karsten Gronert, Andrew Gewirtz, James L. Madara, Charles N. Serhan. Identification of a Human Enterocyte Lipoxin A4 Receptor That Is Regulated by Interleukin (IL)-13 and Interferon γ and Inhibits Tumor Necrosis Factor α–induced IL-8 Release. The Journal of Experimental Medicine 1998, 187 (8) , 1285-1294. https://doi.org/10.1084/jem.187.8.1285
95. Rosario Scalia, Jonathan Gefen, Nicos A. Petasis, Charles N. Serhan, Allan M. Lefer. Lipoxin A 4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: Role of P-selectin. Proceedings of the National Academy of Sciences 1997, 94 (18) , 9967-9972. https://doi.org/10.1073/pnas.94.18.9967
96. Tomoko Takano, Stefano Fiore, Jane F. Maddox, Hugh R. Brady, Nicos A. Petasis, Charles N. Serhan. Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors. The Journal of Experimental Medicine 1997, 185 (9) , 1693-1704. https://doi.org/10.1084/jem.185.9.1693
97. Jane F. Maddox, Mohamed Hachicha, Tomoko Takano, Nicos A. Petasis, Valery V. Fokin, Charles N. Serhan. Lipoxin A4 Stable Analogs Are Potent Mimetics That Stimulate Human Monocytes and THP-1 Cells via a G-protein-linked Lipoxin A4 Receptor. Journal of Biological Chemistry 1997, 272 (11) , 6972-6978. https://doi.org/10.1074/jbc.272.11.6972
98. Charles N. Serhan. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): A jungle of cell-cell interactions or a therapeutic opportunity?. Prostaglandins 1997, 53 (2) , 107-137. https://doi.org/10.1016/S0090-6980(97)00001-4
99. Richard D. Ye, Franc¸ois Boulay. Structure and Function of Leukocyte Chemoattractant Receptors. 1997, 221-289. https://doi.org/10.1016/S1054-3589(08)60073-3